Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis
Sara Caputo, Matteo Grioni, Chiara Svetlana Brambillasca, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment
Bo Wu, Xiang Shi, Meixi Jiang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 100
Glycosylation: mechanisms, biological functions and clinical implications
Mengyuan He, Xiangxiang Zhou, Xin Wang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
Immune evasion by cancer stem cells
Hiroyuki Tsuchiya, Goshi Shiota
Regenerative Therapy (2021) Vol. 17, pp. 20-33
Open Access | Times Cited: 98
The role of stem cells in small-cell lung cancer: Evidence from chemoresistance to immunotherapy
Wenwen Guo, Tianyun Qiao, Tian Li
Seminars in Cancer Biology (2022) Vol. 87, pp. 160-169
Open Access | Times Cited: 60
The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure
Claudia Galassi, Martina Musella, Nicoletta Manduca, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2361-2361
Open Access | Times Cited: 56
Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy
Hassan Dianat‐Moghadam, Amir Mahari, Reza Salahlou, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 56
Cancer stem cell in prostate cancer progression, metastasis and therapy resistance
Poornima Verma, Neha Shukla, Shivani Kumari, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188887-188887
Closed Access | Times Cited: 36
Galectins as pivotal components in oncogenesis and immune exclusion in human malignancies
Nikiforos-Ioannis Kapetanakis, Pierre Busson
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
The missing link between cancer stem cells and immunotherapy
Lobna Safwat Ali, Youssef Attia, Sohaila Mourad, et al.
Current Medical Research and Opinion (2024), pp. 1-35
Closed Access | Times Cited: 5
In Vitro Inhibition of Colon Cancer Stem Cells by Natural Polysaccharides Obtained from Wheat Cell Culture
A. S. Murtazina, Yaiza Jiménez-Martínez, Gloria Ruiz Alcalá, et al.
Polymers (2025) Vol. 17, Iss. 8, pp. 1048-1048
Open Access
Deciphering of intra‐tumoural heterogeneity and the interplay between metastasis‐associated meta‐program and myofibroblasts in gastric cancer
Xiongyan Wu, Zhijian Jin, Baolong Li, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 5
Open Access
Galectins in Cancer and the Microenvironment: Functional Roles, Therapeutic Developments, and Perspectives
Chien‐Hsiu Li, Yu‐Chan Chang, Ming‐Hsien Chan, et al.
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1159-1159
Open Access | Times Cited: 27
Trpm8 Expression in Human and Mouse Castration Resistant Prostate Adenocarcinoma Paves the Way for the Preclinical Development of TRPM8-Based Targeted Therapies
Sacha Genovesi, Riccardo Moro, Beatrice Vignoli, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 193-193
Open Access | Times Cited: 17
Sirtuin 2 Exerts Regulatory Functions on Radiation-Induced Myocardial Fibrosis in Mice by Mediating H3K27 Acetylation of Galectin-3 Promoter.
Liyan Chen, Xinyong Cai, Liang Shao, et al.
PubMed (2024) Vol. 40, Iss. 2, pp. 214-224
Closed Access | Times Cited: 2
Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?
Yuanwei Shi, Danting Tang, Xiaoqi Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
GPNMB+Gal‐3+ hepatic parenchymal cells promote immunosuppression and hepatocellular carcinogenesis
Yan Meng, Qiudong Zhao, Yan Sang, et al.
The EMBO Journal (2023) Vol. 42, Iss. 24
Open Access | Times Cited: 6
Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs
Sara Tomei, Ola Ibnaof, Shilpa Ravindran, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1674-1674
Open Access | Times Cited: 14
The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity
Daria S. Chulpanova, Albert A. Rizvanov, Valeriya V. Solovyeva
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 395-395
Open Access | Times Cited: 9
Galectin-3’s Complex Interactions in Pancreatic Ductal Adenocarcinoma: From Cellular Signaling to Therapeutic Potential
Milica Dimitrijevic Stojanovic, Bojan Stojanović, Ivan Radosavljević, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1500-1500
Open Access | Times Cited: 5
Improving cancer immunotherapy by preventing cancer stem cell and immune cell linking in the tumor microenvironment
Dongyu Li, Lei Wang, Bo Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116043-116043
Open Access | Times Cited: 4
Cancer Stem Cells Niche Regulation Within the Tumor Microenvironment
Zainab Siddiqui, Zaffar Equbal, Naoshad Muhammad, et al.
Current Tissue Microenvironment Reports (2024)
Closed Access | Times Cited: 1
Antimicrobial Functions of Galectins from Fish, Mollusks, and Crustaceans: A Review
Qing Song, Qiaoying Li, Yao Yang, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 45, pp. 24895-24907
Closed Access | Times Cited: 1
Stemness regulation in prostate cancer: prostate cancer stem cells and targeted therapy
Hao Liang, Bin Zhou, Pei-Xin Li, et al.
Annals of Medicine (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Biology, Significance and Immune Signaling of Mucin 1 in Hepatocellular Carcinoma
Lekshmi R. Nath, Ayana R. Kumar, Aswathy R. Devan, et al.
Current Cancer Drug Targets (2022) Vol. 22, Iss. 9, pp. 725-740
Closed Access | Times Cited: 6
Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications
Radwa Mohamed, Athar Emam, Mahmoud M. Abdelfattah, et al.
World Journal of Surgical Oncology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top